SCHEMBL9080353

SCHEMBL9080353

CCCCOCN(C)C[Si](C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.35
CYP3A4 P08684 1/20 0.32
HPGD P15428 1/20 0.31
ADRB2 P07550 1/20 0.31
ADRB1 P08588 1/20 0.31
ADRB3 P13945 1/20 0.31
SPHK1 Q9NYA1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5892459 0.82 TSHR (0.46) TSHRSMN1; SMN2CYP3A4HPGDADRB2
SCHEMBL4651934 0.72
SCHEMBL21093891 0.71 HTT (0.41) TSHRSPHK1
SCHEMBL5892540 0.71 TSHR (0.52) TSHRSMN1; SMN2CYP3A4SPHK1
SCHEMBL25337857 0.69 TSHR (0.48) TSHRSMN1; SMN2CYP3A4HPGDADRB2
SCHEMBL24079471 0.69 TSHR (0.48) TSHRSMN1; SMN2CYP3A4HPGDADRB2
SCHEMBL9658698 0.68 HTT (0.43) TSHRSPHK1
SCHEMBL19835199 0.68 HTT (0.43) TSHRSPHK1
SCHEMBL19835254 0.68 HTT (0.43) TSHRSPHK1
SCHEMBL14578415 0.68 TSHR (0.34) TSHRSMN1; SMN2CYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996036604-A1 4-ARYLCYCLOHEPTA[c]PYRROLE ANALGESICS ORTHO PHARMACEUTICAL CORPORATION (US) 1996-11-21 WO disclosed
WO-1996036605-A1 4-ARYLCYCLOPENTA[c]PYRROLE ANALGESICS ORTHO PHARMACEUTICAL CORPORATION (US) 1996-11-21 WO disclosed
US-5541217-A 4-arylcyclopenta[c]pyrrole analgesics ORTHO PHARMACEUTICAL CORPORATION (US) 1996-07-30 US disclosed
US-5523412-A AN UNSUBSTITUTED OR N-ALKYL- OR CYCLOALKYL-SUBSTITUTED PERHYDROCYCLOHEPTA(C)PYRROL-4-ONE ORTHO PHARMACEUTICAL CORPORATION (US) 1996-06-04 US disclosed